Antiangiogenic drugs as a novel anticancer therapeutic strategy which are the more promising agents? What are the clinical developments and indications?

Giampietro Gasparini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)147-162
Number of pages16
JournalCritical Reviews in Oncology/Hematology
Volume26
Issue number3
DOIs
Publication statusPublished - Dec 1997

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this